Published in Clin Oncol on March 01, 1978
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme. Neuro Oncol (2006) 0.85
Immunobiologic aspects of the brain and human gliomas. A review. Am J Pathol (1980) 0.85
A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma. Br J Cancer (1981) 0.83
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM. J Clin Microbiol (1997) 2.60
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
A stratified Wilcoxon-type test for trend. Stat Med (1990) 1.40
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Effect of starvation on the tissue composition of the small intestine in the rat. Am J Physiol (1968) 1.31
Variations in the level of reporting by hospitals to a regional cancer registry. Br J Cancer (1978) 1.29
Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet (1979) 1.29
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
System delay in breast cancer in whites and blacks. Am J Epidemiol (1995) 1.09
Applying Bayesian ideas in drug development and clinical trials. Stat Med (1993) 1.07
Validation of intermediate end points in cancer research. J Natl Cancer Inst (1990) 1.07
Serum dopamine-beta-hydroxylase activity in neuroblastoma. N Engl J Med (1972) 1.05
Improving the quality of data in randomized clinical trials: the COMPACT computer package. COMPACT Steering Committee. Stat Med (1988) 1.03
Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study. Eur J Clin Nutr (2013) 0.99
Energy adjustment methods for nutritional epidemiology: the effect of categorization. Am J Epidemiol (1994) 0.99
Interpretation of energy adjustment models for nutritional epidemiology. Am J Epidemiol (1993) 0.99
Changes in human serum dopamine- -hydroxylase activity with age. Nature (1972) 0.98
Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer (2000) 0.98
Bayesian design and analysis of two x two factorial clinical trials. Biometrics (1997) 0.98
Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics (1998) 0.97
Limitations of mortality data as a guide to comparative lung cancer incidence within an urban area. Public Health (1979) 0.97
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant (2010) 0.97
Measurement error and dietary intake. Adv Exp Med Biol (1998) 0.96
A unified method for monitoring and analysing controlled trials. Stat Med (1994) 0.93
Effect of measurement error on energy-adjustment models in nutritional epidemiology. Am J Epidemiol (1997) 0.92
Dopamine- -hydroxylase activity in mouse neuroblastoma tumors and in cell cultures. Proc Natl Acad Sci U S A (1972) 0.92
A modified approach to estimating sample size for simple logistic regression with one continuous covariate. Stat Med (2010) 0.92
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Oncogene (2009) 0.90
Early stopping of prevention trials when multiple outcomes are of interest: a discussion. Stat Med (1994) 0.90
The impact of stopping rules on heterogeneity of results in overviews of clinical trials. Biometrics (1992) 0.89
A radioimmunoassay of human circulatory dopamine-beta-hydroxylase. Life Sci (1973) 0.89
Serum dopamine-beta-hydroxylase levels in Down's syndrome. Clin Genet (1974) 0.89
The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments. Br J Cancer Suppl (1980) 0.89
Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Bone Marrow Transplant (2012) 0.88
A familial study in serum dopamine-beta-hydroxylase levels in torsion dystonia. Neurology (1974) 0.88
Spontaneous regression of a desmoid tumour. J Bone Joint Surg Br (1986) 0.88
Diet and colorectal cancer: still an open question. J Natl Cancer Inst (1995) 0.87
Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol (2003) 0.87
Pathology review in cancer research. Br J Cancer (1993) 0.87
Seasonal variations in the clinical of presentation of Crohn's disease and ulcerative colitis. Int J Epidemiol (1975) 0.87
The pharmacokinetics of misonidazole in the dog. Eur J Cancer (1979) 0.87
Statistical design of calibration studies. Am J Clin Nutr (1997) 0.87
Serum dopamine-beta-hydroxylase activity in Down's syndrome: a familial study. Res Commun Chem Pathol Pharmacol (1974) 0.85
Studies on dopamine-beta-hydroxylase in mental disorders. J Psychiatr Res (1974) 0.85
The double arch impression technique: a solution to prevent supraocclusion in the indirect restoration. Gen Dent (2001) 0.85
Surrogate end points in cancer research: a critique. Cancer Epidemiol Biomarkers Prev (1996) 0.84
Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease. Lancet (1972) 0.84
Covariate measurement error adjustment for matched case-control studies. Biometrics (2001) 0.83
Use of semiquantitative food frequency questionnaires to estimate the distribution of usual intake. Am J Epidemiol (1996) 0.83
Prognostic factors in metastatic germ cell tumors. Prog Clin Biol Res (1990) 0.83
Register of dietary assessment calibration-validation studies: a status report. Am J Clin Nutr (1997) 0.83
Reversal of cycloheximide-induced amnesia by adrenergic receptor stimulation. Pharmacol Biochem Behav (1977) 0.82
Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel. Anticancer Res (2000) 0.82
Serum dopamine-beta-hydroxylase in familial dysautonomia. J Lab Clin Med (1975) 0.81
Personal adjustments and regimen compliance 1 year after myocardial infarction. Heart Lung (1989) 0.80
Pulsating electromagnetic fields in the treatment of delayed and non-union of fractures: results from a district general hospital. Injury (1985) 0.80
Malignant melanoma of the anorectal region: two cases of prolonged survival. Br J Surg (1984) 0.80
Using replicate observations in observer agreement studies with binary assessments. Biometrics (1991) 0.80
Seminoma metastasis to jaw simulating a primary growth. Br J Clin Pract (1971) 0.80
Sparing of the brain in neonatal undernutrition: amino acid transport and incorporation into brain and muscle. Science (1980) 0.80
Application of 'futures' in the community-level health promotion with special reference to Latin America. Int J Health Plann Manage (1997) 0.79
Influence of a nursing intervention on regimen adherence and societal adjustments postmyocardial infarction. Nurs Res (1988) 0.79
Effects of cycloheximide, a protein synthesis inhibitor, on mouse brain catecholamine biochemistry. Pharmacol Biochem Behav (1982) 0.79
Regimen compliance two years after myocardial infarction. Nurs Res (1991) 0.79
A statistical comparison of different family history scores. Stat Med (2007) 0.79
The effect of cold pressor test in man on serum immunoreactive dopamine-beta-hydroxylase and on dopamine-beta-hydroxylase activity. Res Commun Chem Pathol Pharmacol (1973) 0.79
A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma. Report to the Medical Research Council by the Brain Tumor Working Party. Int J Radiat Oncol Biol Phys (1989) 0.79
Letter: Teratogenic effects of combination chemotherapy. Ann Intern Med (1974) 0.78